Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study assessing tenofovir alafenamide (TAF) in adults with normal hepatic function and those with severe hepatic impairment; completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B Virus | Phase 1 | Status: COMPLETED | Results posted: 2020-12-09